NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano CoccoHuman Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USAMaurizio ScaltritiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAAlexander DrilonWeill Cornell Medical College, New York, NY, USA. [email protected]
2018en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba